ICON plc (ICLR) Misses Q3 EPS by 50c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Truist Securities Reiterates Buy Rating on ICON plc (ICLR)
October 24, 2024 6:29 AM EDTTruist Securities analyst Jailendra Singh reiterated a Buy rating and $363.00 price target on ICON plc (NASDAQ: ICLR)
The analyst comments "Bottom Line. Given the 3Q intra-quarter cautious tone and commentary from the company & its peers, recent results from Medpace (MEDP, Hold), and life science companies, we believe expectations were low heading into the 3Q print. However, the majority of investor cautiousness, in our view, was more around bookings and book to... More
Leerink Partners Reiterates Outperform Rating on ICON plc (ICLR)
October 24, 2024 6:12 AM EDTLeerink Partners analyst Michael Cherny reiterated an Outperform rating and $376.00 price target on ICON plc (NASDAQ: ICLR)
The analyst comments "Bottom Line: Expectations ahead of ICLR's 3Q'24 print were fairly low given end-market pressures and peer CRO results pointing to weak biotech demand. We... More
